Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26F19AY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,862
Award facts
- Contract value 100% obligated
- $1,861.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams) with a ceiling value of $1,861.56. This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The award utilized no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability in meeting federal procurement requirements through competitive awards across multiple therapeutic domains positions it as a critical vendor within DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F19AY?
SPE2DR26F19AY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F19AY worth?
The government has obligated $1,862 on SPE2DR26F19AY.
Is contract SPE2DR26F19AY an order under another contract?
Yes. SPE2DR26F19AY is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19AY competed?
The extent of competition for SPE2DR26F19AY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award